Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-27T07:44:45.831Z Has data issue: false hasContentIssue false
  • English
  • Français

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission

Published online by Cambridge University Press:  27 March 2019

Katherine E. Goodman Open the ORCID record for Katherine E. Goodman [Opens in a new window] ,
Patricia J. Simner ,
Eili Y. Klein ,
Abida Q. Kazmi ,
Avinash Gadala ,
Matthew F. Toerper ,
Scott Levin ,
Pranita D. Tamma ,
Clare Rock  and
Sara E. Cosgrove
...Show all authors
Katherine E. Goodman*
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
Patricia J. Simner
Affiliation:
Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Eili Y. Klein
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland The Center for Disease Dynamics, Economics, and Policy, Washington, DC
Abida Q. Kazmi
Affiliation:
Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Avinash Gadala
Affiliation:
Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland
Matthew F. Toerper
Affiliation:
Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Scott Levin
Affiliation:
Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Pranita D. Tamma
Affiliation:
Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
Clare Rock
Affiliation:
Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland
Sara E. Cosgrove
Affiliation:
Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland
Lisa L. Maragakis
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland
Aaron M. Milstone
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
for the CDC Prevention Epicenters Program
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland The Center for Disease Dynamics, Economics, and Policy, Washington, DC Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland
the CDC MIND-Healthcare Program
Affiliation:
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland The Center for Disease Dynamics, Economics, and Policy, Washington, DC Department of Hospital Epidemiology and Infection Control, The Johns Hopkins Health System, Baltimore, Maryland Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland
*
Author for correspondence: Katherine E. Goodman, Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Targeted screening for carbapenem-resistant organisms (CROs), including carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing organisms (CPOs), remains limited; recent data suggest that existing policies miss many carriers.

Objective:

Our objective was to measure the prevalence of CRO and CPO perirectal colonization at hospital unit admission and to use machine learning methods to predict probability of CRO and/or CPO carriage.

Methods:

We performed an observational cohort study of all patients admitted to the medical intensive care unit (MICU) or solid organ transplant (SOT) unit at The Johns Hopkins Hospital between July 1, 2016 and July 1, 2017. Admission perirectal swabs were screened for CROs and CPOs. More than 125 variables capturing preadmission clinical and demographic characteristics were collected from the electronic medical record (EMR) system. We developed models to predict colonization probabilities using decision tree learning.

Results:

Evaluating 2,878 admission swabs from 2,165 patients, we found that 7.5% and 1.3% of swabs were CRO and CPO positive, respectively. Organism and carbapenemase diversity among CPO isolates was high. Despite including many characteristics commonly associated with CRO/CPO carriage or infection, overall, decision tree models poorly predicted CRO and CPO colonization (C statistics, 0.57 and 0.58, respectively). In subgroup analyses, however, models did accurately identify patients with recent CRO-positive cultures who use proton-pump inhibitors as having a high likelihood of CRO colonization.

Conclusions:

In this inpatient population, CRO carriage was infrequent but was higher than previously published estimates. Despite including many variables associated with CRO/CPO carriage, models poorly predicted colonization status, likely due to significant host and organism heterogeneity.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 5 , May 2019 , pp. 541 - 550
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amit, S, Mishali, H, Kotlovsky, T, Schwaber, MJ, Carmeli, Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect 2015;21:30–34.CrossRefGoogle ScholarPubMed
Balkan, II, Aygun, G, Aydin, S, et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis 2014;26:51–56.CrossRefGoogle Scholar
Ben-David, D, Kordevani, R, Keller, N, et al. Outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18:54–60.CrossRefGoogle ScholarPubMed
Falagas, ME, Tansarli, GS, Karageorgopoulos, DE, Vardakas, KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014;20:1170–1175.CrossRefGoogle ScholarPubMed
Jamulitrat, S, Arunpan, P, Phainuphong, P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai= Chotmaihet thangphaet 2009;92:413–419.Google ScholarPubMed
Kumar, SH, De, AS, Baveja, SM, Gore, MA. Prevalence and risk factors of metallo beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in burn and surgical wards in a tertiary care hospital. J Lab Physician 2012;4:39–42.Google Scholar
Biggest antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/biggest_threats.html. Published 2014. Accessed February 13, 2019.Google Scholar
Hong, DJ, Bae, IK, Jang, I-H, Jeong, SH, Kang, H-K, Lee, K. Epidemiology and characteristics of metallo-β-lactamase–producing Pseudomonas aeruginosa. Infect Chemother 2015;47:81–97.CrossRefGoogle ScholarPubMed
Kim, UJ, Kim, HK, An, JH, Cho, SK, Park, K-H, Jang, H-C. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med J 2014;50:37–44.CrossRefGoogle ScholarPubMed
Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4(148):148ra116.CrossRefGoogle ScholarPubMed
Tamma, PD, Goodman, KE, Harris, AD, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia. Clin Infect Dis 2017;64:257–264.CrossRefGoogle ScholarPubMed
Dickstein, Y, Edelman, R, Dror, T, Hussein, K, Bar-Lavie, Y, Paul, M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect 2016;94:54–59.CrossRefGoogle ScholarPubMed
Giannella, M, Bartoletti, M, Morelli, MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant 2015;15:1708–1715.CrossRefGoogle ScholarPubMed
Macesic, N, Gomez-Simmonds, A, Sullivan, SB, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis 2018;67:905–912.CrossRefGoogle ScholarPubMed
Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Published 2015. Accessed February 13, 2019.Google Scholar
Shimasaki, T, Segreti, J, Tomich, A, Kim, J, Hayden, MK, Lin, MY. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital. Infect Control Hosp Epidemiol 2018;39:1058–1062.CrossRefGoogle Scholar
Goodman, KE, Simner, PJ, Klein, EY, et al. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications? Infect Control Hosp Epidemiol 2018;39:1491–1493.CrossRefGoogle ScholarPubMed
Simner, PJ, Martin, I, Opene, B, Tamma, PD, Carroll, KC, Milstone, AM. Evaluation of multiple methods for the detection of gastrointestinal colonization of carbapenem-resistant organisms from rectal swabs. J Clin Microbiol 2016;54:1664–1667.CrossRefGoogle ScholarPubMed
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 28th edition. Supplement M100S. Wayne, PA: CLSI; 2018.Google Scholar
Pierce, VM, Simner, PJ, Lonsway, DR, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol 2017;55:2321–2333.CrossRefGoogle ScholarPubMed
Breiman, L, Friedman, J, Stone, C, Olshen, R. Classification and Regression Trees. Boca Raton, FL: CRC/Chapman & Hall; 1984.Google Scholar
Duda, RO, Hart, PE, Stork, DG. Pattern Classification, 2nd edition. New York: Wiley-Interscience; 2001.Google Scholar
Roth, JA, Battegay, M, Juchler, F, Vogt, JE, Widmer, AF. Introduction to machine learning in digital healthcare epidemiology. Infect Control Hosp Epidemiol 2018;39:1457–1462.CrossRefGoogle ScholarPubMed
Woodworth, KR, Walters, MS, Weiner, LM, et al. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms—United States, 2006–2017. Morb Mortal Wkly Rep 2018;67:396–401.CrossRefGoogle ScholarPubMed
Logan, LK, Weinstein, RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 2017;215 supp 1:S28–S36.CrossRefGoogle ScholarPubMed
McKinnell, JA, Miller, LG, Eells, SJ, Cui, E, Huang, SS. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013;34:1077–1086.CrossRefGoogle ScholarPubMed
Simner, PJ, Goodman, KE, Carroll, KC, Harris, AD, Han, JH, Tamma, PD. Using patient risk factors to identify whether carbapenem-resistant Enterobacteriaceae infections are caused by carbapenemase-producing organisms. Open Forum Infect Dis 2018;5(5):ofy094.CrossRefGoogle ScholarPubMed
Bhargava, A, Hayakawa, K, Silverman, E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014;35:398–405.CrossRefGoogle ScholarPubMed
Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817–830.CrossRefGoogle ScholarPubMed
Predic, M, Delano, JP, Tremblay, E, Iovine, N, Brown, S, Prins C: risk factors for carbapenem-resistant Enterobacteriaceae infection. Am J Infect Control 2017;45(6 Suppl):S14.CrossRefGoogle Scholar
Torres-Gonzalez, P, Cervera-Hernandez, ME, et al. Factors associated to prevalence and incidence of carbapenem-resistant enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PloS One 2015;10(10):e0139883.CrossRefGoogle Scholar
Armand-Lefevre, L, Angebault, C, Barbier, F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013;57:1488–1495.CrossRefGoogle ScholarPubMed
Cunha, CB, Kassakian, SZ, Chan, R, et al. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: incidence and risk factors. Am J Infect Control 2016;44:126–130.CrossRefGoogle ScholarPubMed
Prabaker, K, Lin, MY, McNally, M, et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012;33:1193–1199.CrossRefGoogle ScholarPubMed
Muscarella, LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc 2014;6:457–474.CrossRefGoogle ScholarPubMed
Prasad, N, Labaze, G, Kopacz, J, et al. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City. Am J Infect Control 2016;44:525–532.CrossRefGoogle ScholarPubMed
Huizinga, P, van den Bergh, MK, van Rijen, M, Willemsen, I, van ‘t Veer, N, Kluytmans, J. Proton pump inhibitor use is associated with extended-spectrum beta-lactamase-producing Enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361–363.CrossRefGoogle ScholarPubMed
D’Agata, EMC, Varu, A, Geffert, SF, et al. Acquisition of multidrug-resistant organisms in the absence of antimicrobials. Clin Infect Dis 2018;67:1437–1440.CrossRefGoogle ScholarPubMed
Mollenkopf, DF, Stull, JW, Mathys, DA, et al. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agent Chemother 2017;61(2). doi: 10.1128/AAC.01298-16.Google ScholarPubMed
Janecko, N, Martz, SL, Avery, BP, et al. Carbapenem-resistant Enterobacter spp. in retail seafood imported from Southeast Asia to Canada. Emerg Infect Dis 2016;22:1675–1677.CrossRefGoogle ScholarPubMed
Martin, EM, Bryant, B, Grogan, TR, et al. Noninfectious hospital adverse events decline after elimination of contact precautions for MRSA and VRE. Infect Control Hosp Epidemiol 2018;39:788–796.CrossRefGoogle ScholarPubMed
Morgan, DJ, Wenzel, RP, Bearman, G. Contact precautions for endemic MRSA and VRE: time to retire legal mandates. JAMA 2017;318:329–330.CrossRefGoogle ScholarPubMed
Supplementary material: File

Goodman et al. supplementary material

Goodman et al. supplementary material 1

Download Goodman et al. supplementary material(File)
File 958.7 KB